News for AbbVie Inc. (4AB.F)

Tech investors have been running for the hills lately, with the Nasdaq giving up all of its 2021 gains. In the meantime, Q.ai's AI systems have found the top trending stocks this month to beat the market.

PUNE, India, March 04, 2021 (GLOBE NEWSWIRE) -- The Global Multiple Sclerosis Drugs Market Share, Trends, Analysis and Forecasts, 2020-2030 provides ...

Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious and

AbbVie Inc. (NYSE:ABBV) Cowen 41st Annual Health Care Conference March 03, 2021, 11:40 AM ET Company Participants Richard Gonzalez - Chairman and CEO Jeffrey Stewart - EVP, Commercial...

Billionaire Leon Cooperman told CNBC on Wednesday he believes rich people would find ways to avoid paying Sen. Elizabeth Warren’s wealth tax if it were...

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma GlobeNewswire March 03, 2021 - BLA submitted with FDA’s breakthrough therapy designation –

Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ ...

Warren Buffett's 2020 Annual Berkshire Hathaway Shareholder Letter, Stocks: BRK.A,BRK.B, Warren Buffett, Charlie Munger, release date:Feb 28, 2021

Warren Buffett's 2020 Annual Berkshire Hathaway Shareholder Letter, Stocks: BRK.A,BRK.B, Warren Buffett, Charlie Munger, release date:Feb 28, 2021

Berkshire Hathaway’s chairman is set Saturday to provide insights into the state of the U.S. economy and markets amid the pandemic.

According to Bloomberg Intelligence, analysts expect a whopping 23.2% increase in earnings per share among S&P 500 companies, up from 22.3% at the start of the year.

For Buffett followers, it’s that magical time of year again.

Pune, India, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the ...

Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectable Market - Forecasts from 2020 to 2025" report has been added to ...

Today, our cannabis expert Don Yocham will show you how there's still time to move on this must-own biotech stock...

Big Pharma Short Percentage Is Below Overall Market, Stocks: GME,AMC,EXPR,LLY,JNJ,MRK,PFE,GILD,AMGN,ABBV,BMY,GS, release date:Feb 23, 2021

Big Pharma Short Percentage Is Below Overall Market, Stocks: GME,AMC,EXPR,LLY,JNJ,MRK,PFE,GILD,AMGN,ABBV,BMY,GS, release date:Feb 23, 2021

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, announced today that it has granted stock options (the “Options”) to its directors, officers and employees to purchase up to 1,100,000 common shares of the Company, exercisable at a price of $0.495. The Options will vest in four equal tranches on each of August 22, 2021; February 22, 2022; August 22, 2022 and February 22, 2023 and expire on February 22, 2024. For more information please see the Company’s Form 11 filing dated February 22, 2021. About Blockchain Foundry Inc. Blockchain Foundry develops and commercializes blockchain-based business solutions and provides consulting services to corporate clients seeking to incorporate blockchain technology into their businesses. Blockchain Foundry Contact Information: Chris MarshPresident [email protected](647) 330-4572

HOUSTON, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Dril-Quip, Inc. (NYSE: DRQ), (the “Company” or “Dril-Quip”) announced today that it will release its fourth quarter and full year 2020 results on Thursday, February 25, 2021 after the close of trading on the New York Stock Exchange. The Company has also scheduled a conference call to discuss its 2020 results and 2021 outlook on Friday, February 26, 2021 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Participants may join the conference call by dialing 1-877-317-6789 (domestic) or 1-412-317-6789 (international). Participants should ask to be connected to the “Dril-Quip Year-end 2020 Conference Call.” The call will also be webcast and available on Dril-Quip’s website at www.dril-quip.com on the “Events and Presentations” page under the “Investors” tab. The earnings release and presentation slides to be discussed on the call will also be available under the “Investors” tab. An audio replay of the call will be available on Dril-Quip’s website approximately two hours following its conclusion. About Dril-Quip Dril-Quip is a leading manufacturer of highly engineered drilling and production equipment for use onshore and offshore, which is particularly well suited for use in deep-water, harsh environments and severe service applications. Investor Relations Contact Blake Holcomb, Director of Investor Relations and Corporate Planning(713) 939-7711 Ext. [email protected]